Response to Comments: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy

This document is a response to public comments on MolDX LCD L39680 regarding molecular biomarkers for risk stratification of indeterminate pulmonary nodules after bronchoscopy. It records the comment period (8/31/2023–10/14/2023), the notice period start (8/08/2024), and the LCD effective date (9/22/2024); it does not itself state coverage, indications, limitations, or claims documentation requirements.

"This document is a response to comments on MolDX LCD L39680 (Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy); comment period 8/31/2023–10/14/..."

Sign up to see full coverage criteria, indications, and limitations.